NCT06310369View on ClinicalTrials.gov

Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2025

Primary Completion Date

October 1, 2025

Study Completion Date

March 1, 2030

Conditions
Bladder Cancer
Interventions
RADIATION

radiation therapy

"Radiation therapy will be given in 20 fractions of 2.75 Gy covering the whole bladder over 4 weeks.~The use of a radiosensitizing agent is mandatory. Each recruiting center will have to choose 2 options of radiosensitizing agents."

All Listed Sponsors
lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK